Results 201 to 210 of about 371,827 (350)

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

open access: yesMed Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu   +8 more
wiley   +1 more source

Peripheral T-cell lymphoma of the lip: a rare case unveiling key insights into diagnosis and management. [PDF]

open access: yesEcancermedicalscience
Ali T   +7 more
europepmc   +1 more source

Tumor Organoids: Breakthroughs in Clinical Decision Making, Drug Development, and Translational Advances Beyond Conventional Models

open access: yesMed Research, EarlyView.
ABSTRACT Tumor organoid models are revolutionizing cancer research by bridging the translational gap between conventional two‐dimensional cell cultures and animal models. This Editorial thoroughly explores the fundamental innovations of patient‐derived organoid technology.
Yimao Wu   +4 more
wiley   +1 more source

Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup. [PDF]

open access: yesSci Adv
Lone WG   +31 more
europepmc   +1 more source

Hidden Insights: Comprehensive Radiological Analysis of Four Skeletal Populations From 13th–19th Century Southern Finland Reveals Neoplastic and Other Lesions Invisible on Bone Surfaces

open access: yesInternational Journal of Osteoarchaeology, EarlyView.
ABSTRACT This study aims to identify lesions confined to the internal structures of bones. A radiographic analysis was performed on 219 archaeological, historical period skeletons from southern Finland. Although the study examines nearly all preserved skeletal elements using plain radiographs, it does not incorporate computed tomography.
Kati Salo   +2 more
wiley   +1 more source

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

open access: yesClinical Cancer Research, 2015
Hyon-Zu Lee   +18 more
semanticscholar   +1 more source

Never say never

open access: yes
Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal   +4 more
wiley   +1 more source

Frailty, Surgical Time, and Surgical Complications Increase Length of Stay Following Large Vestibular Schwannoma Resection

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Patients with large vestibular schwannomas (VS) are at higher risk for adverse outcomes following microsurgical resection. This study aims to identify clinical and radiographic factors that may be predictive of adverse outcomes. Study Design Retrospective chart review. Setting Academic tertiary care center.
Jason L. Steele   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy